https://stock.noler.com/us/stock/assertio-therapeutics-inc https://stock.noler.com/us/stock/assertio-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/assertio-therapeutics-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/accounts-payable-trade-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/assertio-therapeutics-inc/accounts-receivable-gross https://stock.noler.com/us/stock/assertio-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/assertio-therapeutics-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/accrued-marketing-costs-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/accrued-royalties-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/assertio-therapeutics-inc/acquisition-bargain-purchase-gain-recognized-amount https://stock.noler.com/us/stock/assertio-therapeutics-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/assertio-therapeutics-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/assertio-therapeutics-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/assertio-therapeutics-inc/acquisitions https://stock.noler.com/us/stock/assertio-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/assertio-therapeutics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/assertio-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/assertio-therapeutics-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/assertio-therapeutics-inc/advertising-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/assertio-therapeutics-inc/amended-reports-10-q https://stock.noler.com/us/stock/assertio-therapeutics-inc/amortization https://stock.noler.com/us/stock/assertio-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/assertio-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/assertio-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/assertio-therapeutics-inc/aoci https://stock.noler.com/us/stock/assertio-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/assertio-therapeutics-inc/assets-fair-value-disclosure-recurring https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-change-in-net-unrealized-holding-gain-loss-net-of-tax https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-debt-unrealized-loss-position-number-of-positions https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions-1 https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-unrealized-loss-position-aggregate-losses https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-unrealized-loss-position-aggregate-losses-2 https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-unrealized-loss-position-fair-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-unrealized-loss-position-less-than-12-months-aggregate-losses https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-unrealized-loss-position-less-than-12-months-aggregate-losses-2 https://stock.noler.com/us/stock/assertio-therapeutics-inc/available-for-sale-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/assertio-therapeutics-inc/business-acquisition-contingent-consideration-at-fair-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/business-acquisition-cost-of-acquired-entity-cash-paid https://stock.noler.com/us/stock/assertio-therapeutics-inc/business-acquisition-cost-of-acquired-entity-purchase-price https://stock.noler.com/us/stock/assertio-therapeutics-inc/business-acquisition-purchase-price-allocation-amortizable-intangible-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/business-acquisition-purchase-price-allocation-current-assets-inventory https://stock.noler.com/us/stock/assertio-therapeutics-inc/business-acquisition-purchase-price-allocation-current-assets-prepaid-expense-and-other-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/business-acquisition-purchase-price-allocation-current-liabilities https://stock.noler.com/us/stock/assertio-therapeutics-inc/business-acquisition-purchase-price-allocation-other-noncurrent-liabilities https://stock.noler.com/us/stock/assertio-therapeutics-inc/business-acquisition-purchase-price-allocation-property-plant-and-equipment https://stock.noler.com/us/stock/assertio-therapeutics-inc/business-exit-costs https://stock.noler.com/us/stock/assertio-therapeutics-inc/buybacks-early-repayment-of-senior-debt https://stock.noler.com/us/stock/assertio-therapeutics-inc/buybacks-form-sc-to-i https://stock.noler.com/us/stock/assertio-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/assertio-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/assertio-therapeutics-inc/capital-leases-balance-sheet-assets-by-major-class-net https://stock.noler.com/us/stock/assertio-therapeutics-inc/cash https://stock.noler.com/us/stock/assertio-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/assertio-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/assertio-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/assertio-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/assertio-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/assertio-therapeutics-inc/clinical-trials https://stock.noler.com/us/stock/assertio-therapeutics-inc/commercial-paper-at-carrying-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/common-stock-no-par-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/assertio-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/assertio-therapeutics-inc/contract-with-customer-asset-net https://stock.noler.com/us/stock/assertio-therapeutics-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/assertio-therapeutics-inc/convertible-securities-retired https://stock.noler.com/us/stock/assertio-therapeutics-inc/cost-of-goods-and-service-excluding-depreciation-depletion-and-amortization https://stock.noler.com/us/stock/assertio-therapeutics-inc/cost-of-goods-sold https://stock.noler.com/us/stock/assertio-therapeutics-inc/cost-of-goods-sold-excluding-depreciation-depletion-and-amortization https://stock.noler.com/us/stock/assertio-therapeutics-inc/costs-and-expenses https://stock.noler.com/us/stock/assertio-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/assertio-therapeutics-inc/current-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/assertio-therapeutics-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/assertio-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/assertio-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/assertio-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/assertio-therapeutics-inc/customer-refund-liability-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/assertio-therapeutics-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/assertio-therapeutics-inc/debt-repaid https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-revenue-2 https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-expense-from-stock-options-exercised https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/assertio-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/assertio-therapeutics-inc/depreciation https://stock.noler.com/us/stock/assertio-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/assertio-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/assertio-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/assertio-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/assertio-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/assertio-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/eps https://stock.noler.com/us/stock/assertio-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/assertio-therapeutics-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/assertio-therapeutics-inc/excess-tax-benefit-from-share-based-compensation-operating-activities https://stock.noler.com/us/stock/assertio-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/assertio-therapeutics-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/assertio-therapeutics-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/assertio-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/assertio-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/assertio-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/assertio-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/assertio-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/assertio-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/assertio-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/assertio-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/assertio-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/assertio-therapeutics-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/assertio-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/assertio-therapeutics-inc/gain-loss-on-contract-termination https://stock.noler.com/us/stock/assertio-therapeutics-inc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/assertio-therapeutics-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/assertio-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/assertio-therapeutics-inc/gross-profit https://stock.noler.com/us/stock/assertio-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/assertio-therapeutics-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/assertio-therapeutics-inc/impairment-of-investments https://stock.noler.com/us/stock/assertio-therapeutics-inc/income-tax https://stock.noler.com/us/stock/assertio-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/assertio-therapeutics-inc/income-tax-expense-benefit-intraperiod-tax-allocation https://stock.noler.com/us/stock/assertio-therapeutics-inc/income-tax-receivable https://stock.noler.com/us/stock/assertio-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-deferred-compensation https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-due-from-related-parties-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/assertio-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/assertio-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/assertio-therapeutics-inc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/assertio-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/assertio-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/assertio-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/interest-expense-borrowings https://stock.noler.com/us/stock/assertio-therapeutics-inc/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/assertio-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/assertio-therapeutics-inc/interest-on-convertible-debt-net-of-tax https://stock.noler.com/us/stock/assertio-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/assertio-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/assertio-therapeutics-inc/interest-payable-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/inventory https://stock.noler.com/us/stock/assertio-therapeutics-inc/inventory-finished-goods https://stock.noler.com/us/stock/assertio-therapeutics-inc/inventory-gross https://stock.noler.com/us/stock/assertio-therapeutics-inc/inventory-raw-materials https://stock.noler.com/us/stock/assertio-therapeutics-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/assertio-therapeutics-inc/inventory-work-in-process https://stock.noler.com/us/stock/assertio-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/assertio-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/assertio-therapeutics-inc/investment-income-nonoperating https://stock.noler.com/us/stock/assertio-therapeutics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/assertio-therapeutics-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/assertio-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/assertio-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/assertio-therapeutics-inc/lessor-operating-lease-payments-to-be-received-next-twelve-months https://stock.noler.com/us/stock/assertio-therapeutics-inc/lessor-operating-lease-payments-to-be-received-three-years https://stock.noler.com/us/stock/assertio-therapeutics-inc/lessor-operating-lease-payments-to-be-received-two-years https://stock.noler.com/us/stock/assertio-therapeutics-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/assertio-therapeutics-inc/level-3-liability-transfers-net https://stock.noler.com/us/stock/assertio-therapeutics-inc/liabilities-assumed https://stock.noler.com/us/stock/assertio-therapeutics-inc/liabilities-fair-value-disclosure-recurring https://stock.noler.com/us/stock/assertio-therapeutics-inc/license-and-services-revenue https://stock.noler.com/us/stock/assertio-therapeutics-inc/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/assertio-therapeutics-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/assertio-therapeutics-inc/line-of-credit-facility-unused-capacity-commitment-fee-percentage https://stock.noler.com/us/stock/assertio-therapeutics-inc/long-term-debt-and-capital-lease-obligations-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/long-term-investments https://stock.noler.com/us/stock/assertio-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/marketable-securities-noncurrent https://stock.noler.com/us/stock/assertio-therapeutics-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/assertio-therapeutics-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/net-cash-from https://stock.noler.com/us/stock/assertio-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/assertio-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/assertio-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/assertio-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/assertio-therapeutics-inc/net-income https://stock.noler.com/us/stock/assertio-therapeutics-inc/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/assertio-therapeutics-inc/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/assertio-therapeutics-inc/notes-receivable-gross https://stock.noler.com/us/stock/assertio-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/assertio-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/assertio-therapeutics-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/assertio-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-income https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/assertio-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-income https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-inventory-capitalized-costs https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-noncash-income-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-nonoperating-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-restructuring-costs https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-selling-general-and-administrative-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/assertio-therapeutics-inc/paid-in-capital-share-based-compensation-nonvested-shares-requisite-service-period-recognition https://stock.noler.com/us/stock/assertio-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/assertio-therapeutics-inc/patents-active https://stock.noler.com/us/stock/assertio-therapeutics-inc/payment-for-contingent-consideration-liability-financing-activities https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-for-proceeds-from-businesses-and-interest-in-affiliates https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-for-proceeds-from-tenant-allowance https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-for-rent https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-for-restructuring https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-of-debt-extinguishment-costs https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-to-acquire-loans-receivable https://stock.noler.com/us/stock/assertio-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/assertio-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/assertio-therapeutics-inc/preferred-stock-no-par-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/assertio-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/assertio-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/assertio-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/assertio-therapeutics-inc/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/assertio-therapeutics-inc/proceeds-from-issuance-of-senior-long-term-debt https://stock.noler.com/us/stock/assertio-therapeutics-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/assertio-therapeutics-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/assertio-therapeutics-inc/proceeds-from-sale-of-intangible-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/proceeds-from-sale-of-other-assets-investing-activities https://stock.noler.com/us/stock/assertio-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/assertio-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/assertio-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/assertio-therapeutics-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/assertio-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/assertio-therapeutics-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/assertio-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/assertio-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/assertio-therapeutics-inc/public-float https://stock.noler.com/us/stock/assertio-therapeutics-inc/purchase-obligation https://stock.noler.com/us/stock/assertio-therapeutics-inc/realized-gains-on-securities https://stock.noler.com/us/stock/assertio-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/assertio-therapeutics-inc/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/assertio-therapeutics-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/assertio-therapeutics-inc/research-and-development-in-process https://stock.noler.com/us/stock/assertio-therapeutics-inc/restricted-cash-and-investments-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/restructuring-and-related-cost-expected-cost-remaining https://stock.noler.com/us/stock/assertio-therapeutics-inc/restructuring-charges https://stock.noler.com/us/stock/assertio-therapeutics-inc/restructuring-reserve https://stock.noler.com/us/stock/assertio-therapeutics-inc/restructuring-reserve-accelerated-depreciation https://stock.noler.com/us/stock/assertio-therapeutics-inc/restructuring-reserve-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/restructuring-reserve-settled-without-cash https://stock.noler.com/us/stock/assertio-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/assertio-therapeutics-inc/revenue https://stock.noler.com/us/stock/assertio-therapeutics-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/assertio-therapeutics-inc/royalty-revenue https://stock.noler.com/us/stock/assertio-therapeutics-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/assertio-therapeutics-inc/sales-revenue-net https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-10-k405 https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-10ksb https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-10ksb40 https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-10qsb https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-15-12b https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-25 https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-25-nse https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-425 https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-8-k12b https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-ars https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-ct-order https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-defa14a https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-defc14a https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-defn14a https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-dfan14a https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-prec14a https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-pren14a https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-prer14a https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-prrn14a https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-px14a6g https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-regdex https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/assertio-therapeutics-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-305b2 https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-424a https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/assertio-therapeutics-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/assertio-therapeutics-inc/selling-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/senior-long-term-notes https://stock.noler.com/us/stock/assertio-therapeutics-inc/senior-notes-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/severance-costs https://stock.noler.com/us/stock/assertio-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/assertio-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/assertio-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/assertio-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-compensation-cash-received-from-exercise-of-stock-options https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-granted-value-share-based-compensation https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-issued-shares-issued-value-employee-stock-ownership-plan https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/assertio-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/sublease-income https://stock.noler.com/us/stock/assertio-therapeutics-inc/supplemental-unemployment-benefits-continuation-of-health-care https://stock.noler.com/us/stock/assertio-therapeutics-inc/supplemental-unemployment-benefits-other-postemployment https://stock.noler.com/us/stock/assertio-therapeutics-inc/supplemental-unemployment-benefits-salary-continuation https://stock.noler.com/us/stock/assertio-therapeutics-inc/supplemental-unemployment-benefits-severance-benefits https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-reconciliation-nondeductible-expense-meals-and-entertainment https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/assertio-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/assertio-therapeutics-inc/taxes-payable-current https://stock.noler.com/us/stock/assertio-therapeutics-inc/total-assets https://stock.noler.com/us/stock/assertio-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/assertio-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/assertio-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/assertio-therapeutics-inc/us-government-agencies-securities-at-carrying-value https://stock.noler.com/us/stock/assertio-therapeutics-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/assertio-therapeutics-inc/utb-income-tax-penalties-accrued https://stock.noler.com/us/stock/assertio-therapeutics-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/assertio-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/assertio-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/assertio-therapeutics-inc/utb-interest-on-income-taxes-accrued https://stock.noler.com/us/stock/assertio-therapeutics-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/assertio-therapeutics-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/assertio-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/assertio-therapeutics-inc/valuation-allowances-and-reserves-adjustments https://stock.noler.com/us/stock/assertio-therapeutics-inc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/assertio-therapeutics-inc/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/assertio-therapeutics-inc/valuation-allowances-and-reserves-deductions https://stock.noler.com/us/stock/assertio-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted